Jincao Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jincao Chen has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
Jibo Zhang
Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, China
13 shared publicationsZixuan Wei
Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, China
5 shared publicationsJin Yu
Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China
3 shared publicationsPan Nie
Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, P. R. China
3 shared publications- Wenyuan Zhao
Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, China
3 shared publications Yu Feng
Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China
3 shared publications
Latest Publications
- Open Access
- 7 August 2026
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 168  (1)
Clinical utility of SPECT/CT radionuclide shuntgraphy in suspected ventriculoperitoneal shunt dysfunction
Objective This study aims to develop and validate a more efficient diagnostic system for suspected ventriculoperitoneal shunt dysfunction by integrating traditional radionuclide shuntgraphy with SPECT imaging. Methods This retrospective study examined patients with suspected shunt malfunction admitted to our neurosurgery department from 2021 to 2024, who underwent SPECT/CT imaging of the ventricular shunt. SPECT/CT results were categorized as three groups based on tracer behavior: normal shunt function, partial obstruction, and shunt obstruction. Baseline data, imaging characteristics and clinical management were recorded. Diagnostic agreement with surgery was analyzed only in patients who underwent revision, the only subgroup with a definitive intraoperative reference standard. Result A study of 46 SPECT/CT images from 42 patients found 14 normal shunt functions, 23 with partial obstruction, and 9 with complete obstruction. Nineteen patients underwent surgery, and SPECT/CT demonstrated good agreement with intraoperative findings (16/19), corresponding to a sensitivity of 88.9%. Specificity could not be reliably estimated because there were no true-negative surgical cases. Thin-slice CT scans assessing shunt catheter position and morphology revealed abnormalities such as malposition of the ventricular or abdominal catheter, tortuosity in the abdominal segment, and obstruction or rupture of the catheter body. Abnormal shunt tube positioning or morphology was more prevalent in the obstruction group (p = 0.0083). Conclusion In this heterogeneous clinical population, the SPECT/CT shunt imaging diagnostic system prove0d feasible and clinically informative.
- 7 August 2026
- Published by Springer Nature in Acta Neurochirurgica
- Vol. 168  (1)
Open AccessClinical utility of SPECT/CT radionuclide shuntgraphy in suspected ventriculoperitoneal shunt dysfunction
Objective This study aims to develop and validate a more efficient diagnostic system for suspected ventriculoperitoneal shunt dysfunction by integrating traditional radionuclide shuntgraphy with SPECT imaging. Methods This retrospective study examined patients with suspected shunt malfunction admitted to our neurosurgery department from 2021 to 2024, who underwent SPECT/CT imaging of the ventricular shunt. SPECT/CT results were categorized as three groups based on tracer behavior: normal shunt function, partial obstruction, and shunt obstruction. Baseline data, imaging characteristics and clinical management were recorded. Diagnostic agreement with surgery was analyzed only in patients who underwent revision, the only subgroup with a definitive intraoperative reference standard. Result A study of 46 SPECT/CT images from 42 patients found 14 normal shunt functions, 23 with partial obstruction, and 9 with complete obstruction. Nineteen patients underwent surgery, and SPECT/CT demonstrated good agreement with intraoperative findings (16/19), corresponding to a sensitivity of 88.9%. Specificity could not be reliably estimated because there were no true-negative surgical cases. Thin-slice CT scans assessing shunt catheter position and morphology revealed abnormalities such as malposition of the ventricular or abdominal catheter, tortuosity in the abdominal segment, and obstruction or rupture of the catheter body. Abnormal shunt tube positioning or morphology was more prevalent in the obstruction group (p = 0.0083). Conclusion In this heterogeneous clinical population, the SPECT/CT shunt imaging diagnostic system prove0d feasible and clinically informative.
- Open Access
- 8 May 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1744723
Capillary hemangioma involving both intracranial and entire spinal dura: a case report
Background: Capillary hemangiomas of the central nervous system are exceedingly rare. Previously documented cases have predominantly been located in the intracranial or spinal regions, with the majority presenting as solitary focal lesions. Case description: A 57-year-old woman complained back pain, urinary problems, and numbness and weakness in the lower extremities. MRI revealed thickening and enhancement of the entire spinal dura mater, anomalous enhancement signals surrounding cerebral blood vessels, and DSA revealed multiple malformed vascular clusters in the intracranial and spinal cord regions. Subsequently, a dural biopsy confirmed the pathological diagnosis of capillary hemangioma, with further whole-genome sequencing to identify potential gene mutations. Conclusions: Central nervous system capillary hemangiomas can affect the entire spinal cord and intracranial meningeal tissues simultaneously. Genetic alterations, including PDE4DIP mutations, were identified, but their clinical significance remains unclear.
- 8 May 2026
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1744723
Open AccessCapillary hemangioma involving both intracranial and entire spinal dura: a case report
Background: Capillary hemangiomas of the central nervous system are exceedingly rare. Previously documented cases have predominantly been located in the intracranial or spinal regions, with the majority presenting as solitary focal lesions. Case description: A 57-year-old woman complained back pain, urinary problems, and numbness and weakness in the lower extremities. MRI revealed thickening and enhancement of the entire spinal dura mater, anomalous enhancement signals surrounding cerebral blood vessels, and DSA revealed multiple malformed vascular clusters in the intracranial and spinal cord regions. Subsequently, a dural biopsy confirmed the pathological diagnosis of capillary hemangioma, with further whole-genome sequencing to identify potential gene mutations. Conclusions: Central nervous system capillary hemangiomas can affect the entire spinal cord and intracranial meningeal tissues simultaneously. Genetic alterations, including PDE4DIP mutations, were identified, but their clinical significance remains unclear.
- Open Access
- 31 January 2026
- Published by Elsevier in Brain Research Bulletin
- Vol. 236, 111757
LncRNA Dleu2 regulates fear extinction memory through Celf2-driven synaptic plasticity
- 31 January 2026
- Published by Elsevier in Brain Research Bulletin
- Vol. 236, 111757
Open AccessLncRNA Dleu2 regulates fear extinction memory through Celf2-driven synaptic plasticity
- 30 December 2025
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 145, 111829
The utility of high-resolution magnetic resonance imaging in the detection of fibrotic plaques associated with chronic internal carotid artery occlusion
- 30 December 2025
- Published by Elsevier in Journal of Clinical Neuroscience
- Vol. 145, 111829
The utility of high-resolution magnetic resonance imaging in the detection of fibrotic plaques associated with chronic internal carotid artery occlusion
- 12 December 2025
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 481  (2) , 995-1009
Senescent cell clearance suppresses post-radiotherapy glioblastoma recurrence via the IL-6/JAK2/STAT3 pathway
- 12 December 2025
- Published by Springer Nature in Molecular and Cellular Biochemistry
- Vol. 481  (2) , 995-1009
Senescent cell clearance suppresses post-radiotherapy glioblastoma recurrence via the IL-6/JAK2/STAT3 pathway
- Open Access
- 14 October 2025
- Published by Springer Nature in Cell & Bioscience
- Vol. 15  (1) , 1-22
USP43 promotes cerebral ischemia–reperfusion injury via activation of TAK1
Neuroinflammation and apoptosis are important processes of cerebral ischemia–reperfusion injury. USP43 has been shown to play an important role in a variety of cancers, but its function in the field of neuroscience is unclear. We used an ischemia–reperfusion model of transient embolization of the middle cerebral artery in mice and found that USP43 protein expression was elevated in mice after ischemia–reperfusion injury. Usp43 knockout reduced cerebral infarct volume, inflammatory response, and cell apoptosis, compared to control mice. In vitro, we used an oxygen-glucose-deprived primary neuronal model of rat cortex. Compared with the control group, the Usp43 knockdown group had better cell activity, and the inflammatory response and apoptosis were reduced. Cells in the Usp43 overexpression group exhibited the opposite performance. Mechanistically, we found that USP43 directly interacts with TAK1 by exerting its function as a deubiquitinating enzyme, removing the K48 chain ubiquitination of TAK1 and activating the TAK1-JNK/p38 signaling pathway. Inhibition of USP43 enzyme activity or the use of TAK1 inhibitors can reverse the inflammatory response and neuronal apoptosis induced by USP43 overexpression. These results suggest that USP43 promotes I–R damage by activating TAK1 and its downstream signaling pathways. Inhibition of USP43 may be a potential treatment modality for acute stroke.
- 14 October 2025
- Published by Springer Nature in Cell & Bioscience
- Vol. 15  (1) , 1-22
Open AccessUSP43 promotes cerebral ischemia–reperfusion injury via activation of TAK1
Neuroinflammation and apoptosis are important processes of cerebral ischemia–reperfusion injury. USP43 has been shown to play an important role in a variety of cancers, but its function in the field of neuroscience is unclear. We used an ischemia–reperfusion model of transient embolization of the middle cerebral artery in mice and found that USP43 protein expression was elevated in mice after ischemia–reperfusion injury. Usp43 knockout reduced cerebral infarct volume, inflammatory response, and cell apoptosis, compared to control mice. In vitro, we used an oxygen-glucose-deprived primary neuronal model of rat cortex. Compared with the control group, the Usp43 knockdown group had better cell activity, and the inflammatory response and apoptosis were reduced. Cells in the Usp43 overexpression group exhibited the opposite performance. Mechanistically, we found that USP43 directly interacts with TAK1 by exerting its function as a deubiquitinating enzyme, removing the K48 chain ubiquitination of TAK1 and activating the TAK1-JNK/p38 signaling pathway. Inhibition of USP43 enzyme activity or the use of TAK1 inhibitors can reverse the inflammatory response and neuronal apoptosis induced by USP43 overexpression. These results suggest that USP43 promotes I–R damage by activating TAK1 and its downstream signaling pathways. Inhibition of USP43 may be a potential treatment modality for acute stroke.
- Open Access
WITHDRAWN: Radiation-induced non-neoplastic cells senescence promoting the proliferation and invasiveness of GBM through SASP/JAK2-STAT3 Pathway
Objective To investigate the impact of radiation-induced senescent tumor microenvironment on the proliferation and aggressiveness of GBM, as well as its underlying mechanism. Methods Pre-irradiate astrocytes or mice for the in vitro and in vivo establishment of senescent environments. Simulate the impact of the senescent microenvironment on GBM by treating tumor cells with conditioned medium and utilizing a xenograft tumor model, followed by observation and documentation of the biological characteristics of tumor cells and survival time of mice. The anti-senescence drug was used to eliminate senescent cells in the brain of mice after radiation. Results Astrocytes can be obviously stained by β-galactosidase staining after exposed to X-ray, and the expression of P16 and P21 genes is significantly upregulated. Cell viability assay, transwell invasion assay and wound healing assay demonstrated that GBM cells treated with senescence medium exhibited enhanced proliferation, increased migration and invasion capabilities compared to those treated with normal medium. Irradiated mice displayed larger tumor volume 20 days after tumor implantation and shorter survival times than mice in control group. Administration of navitoclax reduced tumor volume and extended survival time in mice. The transcriptome sequencing and protein detection identified IL6 as the exclusive highly expressed senescence secretion phenotype in senescence medium, which activates the JAK2-STAT3 signaling pathway in tumor cells. Conclusion The tumor microenvironment, consisting of non-neoplastic cell senescence induced by radiotherapy and its secretory phenotype, can facilitate the proliferation and invasion of GBM, indicating the favorable role of senescent cells in the recurrence of residual GBM. This process is mediated through the activation of JAK2-STAT3 signaling pathway by SASP factor IL6. Anti-senescence drugs may emerge as a novel adjunctive therapeutic approach to delay GBM recurrence.
Open AccessWITHDRAWN: Radiation-induced non-neoplastic cells senescence promoting the proliferation and invasiveness of GBM through SASP/JAK2-STAT3 Pathway
Objective To investigate the impact of radiation-induced senescent tumor microenvironment on the proliferation and aggressiveness of GBM, as well as its underlying mechanism. Methods Pre-irradiate astrocytes or mice for the in vitro and in vivo establishment of senescent environments. Simulate the impact of the senescent microenvironment on GBM by treating tumor cells with conditioned medium and utilizing a xenograft tumor model, followed by observation and documentation of the biological characteristics of tumor cells and survival time of mice. The anti-senescence drug was used to eliminate senescent cells in the brain of mice after radiation. Results Astrocytes can be obviously stained by β-galactosidase staining after exposed to X-ray, and the expression of P16 and P21 genes is significantly upregulated. Cell viability assay, transwell invasion assay and wound healing assay demonstrated that GBM cells treated with senescence medium exhibited enhanced proliferation, increased migration and invasion capabilities compared to those treated with normal medium. Irradiated mice displayed larger tumor volume 20 days after tumor implantation and shorter survival times than mice in control group. Administration of navitoclax reduced tumor volume and extended survival time in mice. The transcriptome sequencing and protein detection identified IL6 as the exclusive highly expressed senescence secretion phenotype in senescence medium, which activates the JAK2-STAT3 signaling pathway in tumor cells. Conclusion The tumor microenvironment, consisting of non-neoplastic cell senescence induced by radiotherapy and its secretory phenotype, can facilitate the proliferation and invasion of GBM, indicating the favorable role of senescent cells in the recurrence of residual GBM. This process is mediated through the activation of JAK2-STAT3 signaling pathway by SASP factor IL6. Anti-senescence drugs may emerge as a novel adjunctive therapeutic approach to delay GBM recurrence.
- Open Access
- 17 January 2024
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1344672
The effectiveness of combined resection and radiotherapy for primary pineal malignant melanoma: a systematic review
Objective: To evaluate the effectiveness of combined resection and radiotherapy (CRAR) for the treatment of primary pineal malignant melanoma (PPMM).Methods: Relevant studies were identified through a literature search in PubMed, Embase, and Web of Science from 1899 to September 1, 2023. Then we further screened the literature according to the updated PRISMA 2020 guidelines. The article information, patient information, treatment, and survival rate were analyzed. The primary outcome measures the survival rate of CRAR compared with the overall patients and the patients without treatment. Secondary outcome measures operation methods, radiotherapy methods, and dose.Results: In total, 28 published articles were recorded. Among them, 35.71% (10/28) articles were on CRAR. The median overall survival, CRAR, and no treatment survival were 65, 88, and 12 weeks, respectively. The median overall survival of CRAR was demonstrably better than that of no treatment (p < 0.0001) and overall survival, even with p = 0.1177. Most of the operations adopted a supracerebellar infratentorial approach, and stereotactic radiation to tumor bed usually ranged between 50 and 60 Gy. Small dose and multiple fractions was the most popular radiotherapy method.Conclusion: Currently, CRAR, compared with other treatments, is more beneficial to prolonging the survival of PPMM patients. However, many more clinical cases are needed to verify it as the best treatment approach.
- 17 January 2024
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1344672
Open AccessThe effectiveness of combined resection and radiotherapy for primary pineal malignant melanoma: a systematic review
Objective: To evaluate the effectiveness of combined resection and radiotherapy (CRAR) for the treatment of primary pineal malignant melanoma (PPMM).Methods: Relevant studies were identified through a literature search in PubMed, Embase, and Web of Science from 1899 to September 1, 2023. Then we further screened the literature according to the updated PRISMA 2020 guidelines. The article information, patient information, treatment, and survival rate were analyzed. The primary outcome measures the survival rate of CRAR compared with the overall patients and the patients without treatment. Secondary outcome measures operation methods, radiotherapy methods, and dose.Results: In total, 28 published articles were recorded. Among them, 35.71% (10/28) articles were on CRAR. The median overall survival, CRAR, and no treatment survival were 65, 88, and 12 weeks, respectively. The median overall survival of CRAR was demonstrably better than that of no treatment (p < 0.0001) and overall survival, even with p = 0.1177. Most of the operations adopted a supracerebellar infratentorial approach, and stereotactic radiation to tumor bed usually ranged between 50 and 60 Gy. Small dose and multiple fractions was the most popular radiotherapy method.Conclusion: Currently, CRAR, compared with other treatments, is more beneficial to prolonging the survival of PPMM patients. However, many more clinical cases are needed to verify it as the best treatment approach.
- Open Access
- 11 January 2024
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1333665
The Third Hand of Neurosurgeons – a novel intraoperative malleable adjustable continuous suction tube
Objective: We designed a novel intraoperative malleable adjustable continuous suction tube to obtain clear surgical fields, reduce intracranial pressure, and lower the temperature of the surgical area.Methods: This device consists of six parts: continuous suction tube head and cotton patty, suction tube, fixed wire position, fixed clip, spiral plastic pressure regulating valve, and tail. It can continuously extract blood, cerebrospinal fluid, and rinsing solution from surgical fields, with minimal contact and trauma to tissues, nerves, and blood vessels, while also having a negligible impact on the surgeon’s focus and procedure.Result: The excellent and safe performance (simple, malleable, adjustable, space-saving, inexpensive, safe, and effective) of this device in clearing the operating field has been proven in more than 2000 neurosurgical operative procedures. We encountered no complications associated with this device, such as cerebral hematoma, postoperative low intracranial pressure, or vascular and nerve injuries.Conclusion: The newly innovated intraoperative malleable adjustable continuous suction tube is effective and safe for microneurosurgery.
- 11 January 2024
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1333665
Open AccessThe Third Hand of Neurosurgeons – a novel intraoperative malleable adjustable continuous suction tube
Objective: We designed a novel intraoperative malleable adjustable continuous suction tube to obtain clear surgical fields, reduce intracranial pressure, and lower the temperature of the surgical area.Methods: This device consists of six parts: continuous suction tube head and cotton patty, suction tube, fixed wire position, fixed clip, spiral plastic pressure regulating valve, and tail. It can continuously extract blood, cerebrospinal fluid, and rinsing solution from surgical fields, with minimal contact and trauma to tissues, nerves, and blood vessels, while also having a negligible impact on the surgeon’s focus and procedure.Result: The excellent and safe performance (simple, malleable, adjustable, space-saving, inexpensive, safe, and effective) of this device in clearing the operating field has been proven in more than 2000 neurosurgical operative procedures. We encountered no complications associated with this device, such as cerebral hematoma, postoperative low intracranial pressure, or vascular and nerve injuries.Conclusion: The newly innovated intraoperative malleable adjustable continuous suction tube is effective and safe for microneurosurgery.
- Open Access
- 9 August 2021
- Published by Springer Nature in BMC Neurology
- Vol. 21  (1) , 1-6
Safety and effectiveness of high flow extracranial to intracranial saphenous vein bypass grafting in the treatment of complex intracranial aneurysms: a single-centre long-term retrospective study
Background: To summarize the safety and effectiveness of high flow extracranial to intracranial saphenous vein bypass grafting in the treatment of complex intracranial aneurysms.Methods: The data of complex intracranial aneurysms patients for high flow extracranial to intracranial saphenous vein bypass grafting from January 2008 to January 2020 were retrospectively collected and analyzed. Eighty-two patients (31 men and 51 women) with 89 aneurysms underwent 82 saphenous vein bypass grafts followed by immediate parent vessel occlusion. The aneurysm was located at the internal carotid artery, middle cerebral artery, and basilar artery in 75, 11, and 3 cases, respectively.Results: The patency rate of bypass grafting was 100, 100, 96.3 and 92.4% on intraoperation, on the first postoperative day, at discharge and 6 months follow-up, respectively. At discharge and 6 months follow-up, 3 and 6 patients had graft occlusions. The main postoperative complications were transient hemiparesis and hemianopsia. 3 patients died due to bypass complications and poor physical condition.Conclusions: High flow extracranial to intracranial saphenous vein bypass grafting is safe and effective in the treatment of complex intracranial aneurysms and the saphenous vein can meet the requirements of brain blood supply. A high rate of graft patency and adequate cerebral blood flow can be achieved.Highlights: A single-centre long-term retrospective study was conducted to assess the safety and effectiveness of high flow EC-IC saphenous vein bypass grafting in the treatment of complex intracranial aneurysms. The data of 82 patients from January 2008 to January 2020 were retrospectively collected and analysed.We found the patency rate of bypass grafting was 100, 100, 96.3 and 92.4% on intraoperation, on the first postoperative day, at discharge and 6 months follow-up, respectively. At discharge and 6 months follow-up, 3 and 6 patients had graft occlusions.Finally, we conclude that high flow extracranial to intracranial saphenous vein bypass grafting is safe and effective in the treatment of complex intracranial aneurysms and the selected blood supply vessels can meet the requirements of blood supply.As far as we know, this study is one of the maximum number of cases in the treatment of complex intracranial aneurysms with saphenous vein bypass.
- 9 August 2021
- Published by Springer Nature in BMC Neurology
- Vol. 21  (1) , 1-6
Open AccessSafety and effectiveness of high flow extracranial to intracranial saphenous vein bypass grafting in the treatment of complex intracranial aneurysms: a single-centre long-term retrospective study
Background: To summarize the safety and effectiveness of high flow extracranial to intracranial saphenous vein bypass grafting in the treatment of complex intracranial aneurysms.Methods: The data of complex intracranial aneurysms patients for high flow extracranial to intracranial saphenous vein bypass grafting from January 2008 to January 2020 were retrospectively collected and analyzed. Eighty-two patients (31 men and 51 women) with 89 aneurysms underwent 82 saphenous vein bypass grafts followed by immediate parent vessel occlusion. The aneurysm was located at the internal carotid artery, middle cerebral artery, and basilar artery in 75, 11, and 3 cases, respectively.Results: The patency rate of bypass grafting was 100, 100, 96.3 and 92.4% on intraoperation, on the first postoperative day, at discharge and 6 months follow-up, respectively. At discharge and 6 months follow-up, 3 and 6 patients had graft occlusions. The main postoperative complications were transient hemiparesis and hemianopsia. 3 patients died due to bypass complications and poor physical condition.Conclusions: High flow extracranial to intracranial saphenous vein bypass grafting is safe and effective in the treatment of complex intracranial aneurysms and the saphenous vein can meet the requirements of brain blood supply. A high rate of graft patency and adequate cerebral blood flow can be achieved.Highlights: A single-centre long-term retrospective study was conducted to assess the safety and effectiveness of high flow EC-IC saphenous vein bypass grafting in the treatment of complex intracranial aneurysms. The data of 82 patients from January 2008 to January 2020 were retrospectively collected and analysed.We found the patency rate of bypass grafting was 100, 100, 96.3 and 92.4% on intraoperation, on the first postoperative day, at discharge and 6 months follow-up, respectively. At discharge and 6 months follow-up, 3 and 6 patients had graft occlusions.Finally, we conclude that high flow extracranial to intracranial saphenous vein bypass grafting is safe and effective in the treatment of complex intracranial aneurysms and the selected blood supply vessels can meet the requirements of blood supply.As far as we know, this study is one of the maximum number of cases in the treatment of complex intracranial aneurysms with saphenous vein bypass.